Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Permeation Enhancer Effect of Chitosan and Chitosan Derivatives: Comparison of Formulations As Soluble Polymers and Nanoparticulate Systems on Insulin Absorption in Caco-2 Cells Publisher Pubmed



Sadeghi AMM1, 3 ; Dorkoosh FA2 ; Avadi MR3 ; Weinhold M4 ; Bayat A5 ; Delie F6 ; Gurny R6 ; Larijani B7 ; Rafieetehrani M5 ; Junginger HE1, 8
Authors
Show Affiliations
Authors Affiliations
  1. 1. Division of Pharmaceutical Technology, Leiden University, Leiden, Netherlands
  2. 2. Department of Pharmaceutics, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Hakim Pharmaceutical Company, Tehran, Iran
  4. 4. UFT - Center for Environmental Research and Technology, Bremen, Germany
  5. 5. Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Pharmaceutics and Biopharmaceutics, University of Geneva, Geneva, Switzerland
  7. 7. Endocrinology Research Center, Shariati Hospital, Tehran, Iran
  8. 8. Naresuan University, Phitsanulok, Thailand

Source: European Journal of Pharmaceutics and Biopharmaceutics Published:2008


Abstract

In this study four quaternized derivatives of chitosan: trimethyl chitosan (TMC), dimethylethyl chitosan (DMEC), diethylmethyl chitosan (DEMC) and triethyl chitosan (TEC) with degree of substitution of approximately 50 ± 5% were synthesized and their effect on the permeability of insulin across intestinal Caco-2 monolayers was studied and compared with chitosan both in free-soluble form and in nanoparticulate systems. Transepithelial electrical resistance (TEER) studies revealed that all four chitosan derivatives in free-soluble forms were able to decrease the TEER value in the following order TMC > DMEC > DEMC = TEC > chitosan, indicating their abilities to open the tight junctions. Recovery studies on the TEER showed that the effect of the polymers on Caco-2 cell monolayer is reversible and proves the viability of cells after incubation with all polymers. A similar rank order was also observed when measuring the zeta-potentials of the various polymers in solution form. Transport studies of insulin together with the soluble polymers across Caco-2 cell layers showed the following ranking: TMC > DMEC > DEMC > TEC > chitosan which is in agreement with the strength of the cationic charge of the polymer. In comparison to the free-soluble polymers, the nanoparticles prepared by ionic gelation of the chitosan and its quaternized derivatives had much lower effect on decreasing the TEER by opening of the tight junctions. This can be explained by the reduced available amount of positive charge at the surface of the nanoparticles. In accordance with these results, the insulin loaded nanoparticles showed much less permeation across the Caco-2 cell monolayer in comparison to the free-soluble polymers. Mass balance transport studies revealed that a substantial amount of the nanoparticles has been entrapped into the Caco-2 monolayer or attached to the cell surface. It can thus be stated that while free-soluble polymers can reversibly open the tight junctions and increase the permeation of insulin, the nanoparticles had basically only a low effect on the opening of the tight junction and the paracellular transport of insulin across the Caco-2 cell monolayer. These data convincingly show that nanoparticles consisting of chitosan and its quaternary ammonium derivatives loaded with insulin are less effective in facilitating paracellular transport across Caco-2 cell monolayers than the corresponding free polymers. © 2008 International Association for Pharmaceutical Technology.
Experts (# of related papers)
Other Related Docs
14. Nasal Delivery of Insulin Using Bioadhesive Chitosan Gels, Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents (2006)
26. Colon-Specific Delivery of Mesalazine Chitosan Microspheres, Journal of Microencapsulation (2006)
32. Characterization of Plga/Chitosan Electrospun Nano-Biocomposite Fabricated by Two Different Methods, International Journal of Polymeric Materials and Polymeric Biomaterials (2015)
34. Ph-Sensitive Polymers for Cytoplasmic Drug Delivery, Expert Opinion on Therapeutic Patents (2008)
36. What Are the Limitations of Chitosan Use in Non-Viral Gene Delivery and How to Overcome Them?, Biocompatible Nanomaterials: Synthesis, Characterization and Applications (2011)
39. Immobilization of Alkaline Phosphatase Using Chitosan Nanoparticles, Russian Journal of Applied Chemistry (2015)